Friday, July 10, 2026

pharma · Gram-negative Bacterial Infections · SARS-CoV-2 Infection

Shionogi Inc. (U.S.)

Shionogi Inc. (U.S.) trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Florham Park, USA HQ
2001 Founded
601 Employees
EMA registrant Type
Company details
Intelligence · Clinical Trials

Shionogi Inc. (U.S.) clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to Shionogi Inc. (U.S.) programs — each row shows trial ID, program name, phase, status, and indication.

Shionogi Inc. (U.S.) trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Shionogi Inc. (U.S.).

  1. 2402T1432 — Phase 2

    Clinical update
  2. S-268019-b — Phase 3

    Clinical update
  3. S-217622 — Phase 3

    Clinical update
  4. S-606001 matching placebo, S-606001 — Phase 2

    Clinical update
  5. Cefiderocol — Phase 2

    Clinical update
  6. S-337395 — Phase 2

    Clinical update

Trial registry

6 studies